Catherine Legraverend

2.7k total citations
36 papers, 2.0k citations indexed

About

Catherine Legraverend is a scholar working on Molecular Biology, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Catherine Legraverend has authored 36 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Cancer Research and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Catherine Legraverend's work include Carcinogens and Genotoxicity Assessment (10 papers), Growth Hormone and Insulin-like Growth Factors (9 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Catherine Legraverend is often cited by papers focused on Carcinogens and Genotoxicity Assessment (10 papers), Growth Hormone and Insulin-like Growth Factors (9 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Catherine Legraverend collaborates with scholars based in France, United States and Sweden. Catherine Legraverend's co-authors include Daniel W. Nebert, Agneta Mode, Philippe Jay, François Gerbe, Jan-Ακε Gustafsson, Virginie Vives, Jacques Baudier, Christian Delphin, Jean‐Christophe Deloulme and Nicole Assard and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Catherine Legraverend

36 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine Legraverend France	24	904	435	355	337	297	36	2.0k
Jennifer B. Collins United States	28	1.4k 1.5×	239 0.5×	337 0.9×	74 0.2×	299 1.0×	39	2.7k
Jan-Åke Gustafsson Sweden	20	672 0.7×	199 0.5×	352 1.0×	77 0.2×	342 1.2×	27	1.7k
Young Soo Ahn South Korea	27	1.3k 1.4×	283 0.7×	90 0.3×	38 0.1×	245 0.8×	60	2.4k
Magnus Axelson Sweden	27	1.3k 1.4×	369 0.8×	845 2.4×	194 0.6×	629 2.1×	65	2.6k
Venugopal Radjendirane United States	13	1.9k 2.1×	192 0.4×	48 0.1×	98 0.3×	141 0.5×	16	2.3k
Brett T. Spear United States	31	1.8k 1.9×	562 1.3×	85 0.2×	134 0.4×	330 1.1×	94	2.7k
Gopa Biswas United States	25	1.8k 2.0×	358 0.8×	65 0.2×	293 0.9×	238 0.8×	33	2.6k
Michel Pierre France	26	942 1.0×	172 0.4×	315 0.9×	22 0.1×	229 0.8×	47	1.9k
Sei‐itsu Murota Japan	26	811 0.9×	172 0.4×	189 0.5×	81 0.2×	115 0.4×	68	2.0k
Hiroaki Konishi Japan	25	2.7k 3.0×	280 0.6×	165 0.5×	41 0.1×	275 0.9×	60	3.6k

Countries citing papers authored by Catherine Legraverend

Since Specialization

Citations

This map shows the geographic impact of Catherine Legraverend's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Legraverend with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Legraverend more than expected).

Fields of papers citing papers by Catherine Legraverend

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Legraverend. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Legraverend. The network helps show where Catherine Legraverend may publish in the future.

Co-authorship network of co-authors of Catherine Legraverend

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Legraverend. A scholar is included among the top collaborators of Catherine Legraverend based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Legraverend. Catherine Legraverend is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gerbe, François, Catherine Legraverend, & Philippe Jay. (2012). The intestinal epithelium tuft cells: specification and function. Cellular and Molecular Life Sciences. 69(17). 2907–2917. 188 indexed citations

Nicolas, Pierre, Sabine Laurent‐Chabalier, Philippe Clair, et al.. (2011). Intestinal epithelial stem cells do not protect their genome by asymmetric chromosome segregation. Nature Communications. 2(1). 258–258. 51 indexed citations

Legraverend, Catherine & Philippe Jay. (2011). Hierarchy and plasticity in the crypt: back to the drawing board. Cell Research. 21(12). 1652–1654. 3 indexed citations

Hugnot, Jean‐Philippe, et al.. (2007). Expression of S100B during embryonic development of the mouse cerebellum. BMC Developmental Biology. 7(1). 17–17. 36 indexed citations

Agenès, Fabien, Christian Delphin, Nicole Assard, et al.. (2006). S100B expression defines a state in which GFAP‐expressing cells lose their neural stem cell potential and acquire a more mature developmental stage. Glia. 55(2). 165–177. 282 indexed citations

Aguirre, Adán, et al.. (2005). Spatial and temporal expression of S100B in cells of oligodendrocyte lineage. Glia. 51(2). 81–97. 135 indexed citations

Vives, Virginie, et al.. (2003). Visualization of S100B‐positive neurons and glia in the central nervous system of EGFP transgenic mice. The Journal of Comparative Neurology. 457(4). 404–419. 135 indexed citations

Leverrier, Sabrina, C. Paul, Jean Derancourt, et al.. (2000). Purification and Cloning of Type A/B hnRNP Proteins Involved in Transcriptional Activation from the Rat spi 2 Gene GAGA Box. Biological Chemistry. 381(11). 1031–40. 24 indexed citations

Legraverend, Catherine. (1996). A novel growth hormone response element unrelated to STAT (signal transducer and activator of transcription)-binding sites is a bifunctional enhancer. Molecular Endocrinology. 10(12). 1507–1518. 9 indexed citations

10.

Legraverend, Catherine, et al.. (1996). A novel growth hormone response element unrelated to STAT (signal transducer and activator of transcription)-binding sites is a bifunctional enhancer.. Molecular Endocrinology. 10(12). 1507–1518. 22 indexed citations

11.

Legraverend, Catherine, Hidetaka Eguchi, Olivier Lahuna, et al.. (1994). Transactivation of the rat CYP2C13 gene promoter involves HNF-1, HNF-3, and members of the orphan receptor subfamily. Biochemistry. 33(33). 9889–9897. 37 indexed citations

12.

Legraverend, Catherine, et al.. (1993). High level activity of the mouse CCAAT/enhancer binding protein (C/EBPα) gene promoter involves autoregulation and several ubiquitous transcription factors. Nucleic Acids Research. 21(8). 1735–1742. 92 indexed citations

13.

Legraverend, Catherine, Agneta Mode, Timothy Wells, Iain M. Robinson, & Jan-Ακε Gustafsson. (1992). Hepatic steroid hydroxylating enzymes are controlled by the sexually dimorphic pattern of growth hormone secretion in normal and dwarf rats. The FASEB Journal. 6(2). 711–718. 125 indexed citations

14.

Liddle, Christopher, Agneta Mode, Catherine Legraverend, & Jan‐Åke Gustafsson. (1992). Constitutive expression and hormonal regulation of male sexually differentiated cytochromes P450 in primary cultured rat hepatocytes. Archives of Biochemistry and Biophysics. 298(1). 159–166. 58 indexed citations

15.

Legraverend, Catherine, et al.. (1991). A Role for Protein Kinases in the Growth Hormone Regulation of Cytochrome P4502C12 and Insulin-Like Growth Factor-I Messenger RNA Expression in Primary Adult Rat Hepatocytes. Molecular Endocrinology. 5(9). 1351–1358. 49 indexed citations

16.

Legraverend, Catherine, et al.. (1989). Interleukin-2 regulates the activity of ornithine decarboxylase in a cloned murine T lymphocytic cell line: Evidence for a protein kinase C-dependent pathway. Experimental Cell Research. 181(1). 282–288. 5 indexed citations

17.

Legraverend, Catherine, et al.. (1984). DNA binding of [14C]styrene in isolated rat hepatocytes. Chemico-Biological Interactions. 51(1). 91–102. 3 indexed citations

18.

Legraverend, Catherine, Thomas M. Guenthner, & Daniel W. Nebert. (1984). Importance of the route of administration for genetic differences in benzo[a]pyrene‐induced in utero toxicity and teratogenicity. Teratology. 29(1). 35–47. 64 indexed citations

19.

Kahl, G. F., et al.. (1979). Formation of benzo[a]pyrene metabolite-nucleoside adducts in isolated perfused rat and mouse liver and in mouse lung slices. Biochemical Pharmacology. 28(7). 1051–1056. 26 indexed citations

20.

Owens, Ida S., et al.. (1979). Mutagenesis of certain benzo[a]pyrene phenols in vitro following further metabolism by mouse liver. Biochemical Pharmacology. 28(10). 1615–1622. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact